Vol 53, No 3 (2022)

Date published: 2022-06-30

Table of Contents

open access



Jan Styczyński


DOI: 10.5603/AHP.2022.0017
Acta Haematol Pol 2022;53(3):151-152.

Chronic myeloid leukemia: where do we stand, where can we go?

Krzysztof Lewandowski, Jakub Lewandowski

Review article

DOI: 10.5603/AHP.a2022.0012
Acta Haematol Pol 2022;53(3):153-165.

CAR-T therapy in mantle cell lymphoma: a review of the current literature

Joanna Romejko-Jarosińska

Review article

DOI: 10.5603/AHP.a2022.0018
Acta Haematol Pol 2022;53(3):166-175.

Artificial intelligence and chimeric antigen receptor T-cell therapy

Lidia Gil, Maksymilian Grajek

Review article

DOI: 10.5603/AHP.a2022.0019
Acta Haematol Pol 2022;53(3):176-179.

Outpatient CAR-T therapy

Dominik Dytfeld, Lida Gil

Review article

DOI: 10.5603/AHP.a2022.0020
Acta Haematol Pol 2022;53(3):180-182.

Usefulness of training based on outcome of transfusion committee report: assessment by personnel involved in blood therapy

Jolanta Antoniewicz-Papis, Agata Mikołowska, Krzysztof Sutkowski

Original research article

DOI: 10.5603/AHP.a2022.0021
Acta Haematol Pol 2022;53(3):183-190.

Treosulfan-based conditioning vs. low-dose busulfan-based conditioning for allogeneic hematopoietic stem cell transplantation: a cost-utility analysis in Poland

Paweł Kawalec, Przemysław Holko, George Bungey, Owen Moseley, Magdalena Żegleń, Mirosław Markiewicz

Original research article

DOI: 10.5603/AHP.a2022.0022
Acta Haematol Pol 2022;53(3):191-200.

Survival in patients with multiple myeloma: a real-life single-center study

Marek Rodzaj, Anna Morawska-Krekora, Malgorzata Razny, Beata Jakubas

Original research article

DOI: 10.5603/AHP.a2022.0024
Acta Haematol Pol 2022;53(3):201-206.

Vaccinations following CAR-T cell therapy: summary of reported cases and state-of-the-art review of current recommendations

Jan Styczyński, Tomasz Styczyński, Jagoda Sadlok, Magdalena Woźniak, Dorota Rutkowska

Original research article

DOI: 10.5603/AHP.a2022.0025
Acta Haematol Pol 2022;53(3):207-214.

Primary refractory primary mediastinal lymphoma treated with CAR-T: new possibilities and challenges

Krzysztof Żyłka, Dominik Dytfeld, Lidia Gil

Clinical vignette

DOI: 10.5603/AHP.a2022.0026
Acta Haematol Pol 2022;53(3):215-217.

Extramedullary plasmacytoma of the larynx manifesting as chronic hypertrophic laryngitis

Elżbieta Szczepanek, Anna Rzepakowska, Agnieszka Końska, Kazimierz Niemczyk, Iwona Hus, Jakub Grzybowski, Krzysztof Jamroziak

Clinical vignette

DOI: 10.5603/AHP.a2022.0027
Acta Haematol Pol 2022;53(3):218-220.

Role of Bradyrhizobium enterica in gastrointestinal graft-versus-host disease

Cem Selim, Murat Telli, Zahit Ali Bolaman, Irfan Yavaşoğlu

Clinical vignette

DOI: 10.5603/AHP.a2022.0028
Acta Haematol Pol 2022;53(3):221-223.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl